| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.33 | 3e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.32 | 8e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-07 |